Coya Therapeutics, Inc entered into a Securities Purchase Agreement with certain accredited investors for 4,370,382 shares at a price of $6.06 per share of Common Stock for gross proceeds for $26,484,514 on December 5, 2023.The transaction is expected to close on December 11, 2023. The transaction included participation Wilbur Ross, former U.S. Secretary of Commerce and other existing institutional investors.